Mahai Chris LaVictoire, a director of abrdn World Healthcare Fund, purchased 796 shares of Common Stock on 2026-07-16 at $13.20 per share in an open-market or private transaction. Following this trade, LaVictoire directly owns 796 shares of the fund’s Common Stock.
abrdn World Healthcare Fund director Mahai Chris LaVictoire has filed an initial ownership report on Form 3. This filing establishes LaVictoire as a reporting insider of the fund but does not list any share holdings or report any buy, sell, or other transactions.
abrdn World Healthcare Fund filed a preliminary prospectus registering up to $128,000,000 of common shares, preferred shares, notes and subscription rights under a shelf registration to be sold from time to time. The Fund is a diversified, closed-end management investment company focused on healthcare companies and intends to invest at least 80% of its Managed Assets in the healthcare industry.
The prospectus discloses key terms and policies: the Fund’s NAV was $12.72 and the last reported NYSE sale price was $12.80 (a 0.63% premium) as of May 6, 2026; the Fund has 40,363,833.60 common shares outstanding as of that date; it targets monthly distributions of $0.1167 per share; and it currently uses a $120,000,000 revolving credit facility. The Adviser fee is 1.00% of managed assets and total annual expenses are shown as 3.00%.
abrdn World Healthcare Fund reported a new insider with no share ownership. A Form 3 filing shows an individual serving as a Vice President of the fund and therefore an officer of the issuer. The filing states that no securities of abrdn World Healthcare Fund are beneficially owned by this reporting person, and both the non-derivative and derivative ownership tables are blank. The document also includes a power of attorney authorizing the signatory, dated 12/19/2025, and identifies the event date triggering the report as 12/09/2025.